CXCL8 and ovarian cancer: The IL-8 and IL-8 receptors CXCR1 and CXCR2 were reported by Wen et al. [37] and Yen et al. [66] to induce EMT changes in ovarian cancer cells potentially by the Wnt/β-catenin pathway, similarly to TGF-β.